\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-tender\\,\\ non\\-distended\\ abdominal\\ and\\ pelvic\\ exam\\.\\ \\ no\\ adnexal\\ tenderness\\.\\ \\ normal\\ wbc\\ count\\.\\ \\ stable\\ h\\&h\\.\\ \\ quantitative\\ hcg\\ of\\ 909\\ iu\\/l\\.\ \(0\)\
\-\ surgical\\ treatment\\ with\\ periodic\\ follow\\-up\\ evaluations\\ until\\ quantitative\\ hcg\\ returned\\ to\\ zero\\.\ \(0\)\
\-\ transvaginal\\ grayscale\\ and\\ color\\ flow\\ ultrasound\\ evaluation\\ of\\ the\\ pelvis\\ demonstrates\\ a\\ moderate\\ amount\\ of\\ free\\ fluid\\ in\\ pelvic\\ cul\\-de\\-sac\\.\\ \\ no\\ gestational\\ sac\\ is\\ seen\\ within\\ the\\ endometrium\\.\\ \\ there\\ is\\ a\\ heterogeneous\\ mass\\ anterior\\ to\\ right\\ ovary\\ with\\ adjacent\\ complex\\ fluid\\.\ \(0\)\
\-\ ectopic\\ pregnancy\ \(58\)\
\-\ 1\\.\\ ectopic\\ pregnancy\ \(0\)\
\-\ 2\\.\\ early\\ iup\\ \ \(0\)\
\-\ 3\\.\\ nonviable\\ iup\ \(0\)\
\-\ 27y\\/o\\ g0p0\\ white\\ female\\ with\\ 24\\ hours\\ of\\ abdominal\\ \\‚\\Ä\\úqueeziness\\.\\‚\\Ä\\ù\\ \\ last\\ menstrual\\ period\\ 2\\ weeks\\ ago\\,\\ but\\ \\‚\\Ä\\úlighter\\ than\\ usual\\.\\‚\\Ä\\ù\ \(0\)\
\-\ ectopic\\ pregnancy\\ if\\ defined\\ by\\ the\\ implantation\\ of\\ a\\ fertilized\\ ovum\\ outside\\ the\\ \\ endometrial\\ lining\\ of\\ the\\ uterus\\,\\ most\\ commonly\\ within\\ the\\ fallopian\\ tube\\ \\(95\\-97\\%\\)\\.\\ \\ the\\ incidence\\ of\\ ectopic\\ pregnancy\\ increased\\ throughout\\ the\\ 1970\\‚\\Ä\\ôs\\ and\\ 80\\‚\\Ä\\ôs\\,\\ presumably\\ secondary\\ to\\ the\\ increased\\ rate\\ of\\ pelvic\\ inflammatory\\ disease\\.\\ \\ the\\ associated\\ mortality\\ rate\\ decreased\\ following\\ this\\ rise\\ in\\ incidence\\,\\ because\\ of\\ increased\\ awareness\\ and\\ earlier\\ detection\\.\ \(0\)\
\-\ the\\ classic\\ triad\\ of\\ ectopic\\ pregnancy\\ consists\\ of\\ irregular\\ bleeding\\,\\ abdominal\\/pelvic\\ pain\\,\\ and\\ a\\ tender\\ adnexal\\ mass\\.\\ \\ only\\ 60\\%\\ of\\ cases\\ have\\ a\\ missed\\ menstral\\ period\\.\\ \\ signs\\ and\\ symptoms\\ can\\ present\\ early\\,\\ secondary\\ to\\ mass\\ effect\\ on\\ the\\ small\\ caliber\\ fallopian\\ tube\\.\\ \\ high\\ risk\\ groups\\ include\\ females\\ with\\ abnormal\\ fallopian\\ tubes\\ from\\ prior\\ infection\\,\\ developmental\\ defects\\,\\ or\\ prior\\ surgery\\,\\ having\\ an\\ iud\\ in\\ place\\,\\ in\\ vitro\\ fertilization\\,\\ and\\ a\\ prior\\ history\\ of\\ ectopic\\ pregnancy\\.\\ \\ this\\ patient\\ presented\\ with\\ irregular\\ bleeding\\,\\ but\\ without\\ pain\\ or\\ tenderness\\.\\ \\ she\\ had\\ none\\ of\\ the\\ above\\-described\\ risk\\ factors\\.\ \(0\)\
\-\ above\\ a\\ quantitative\\ hcg\\ level\\ of\\ 1500\\-2000\\ iu\\/l\\,\\ an\\ intrauterine\\ pregnancy\\ should\\ be\\ visualized\\ on\\ transvaginal\\ ultrasound\\,\\ if\\ present\\.\\ \\ this\\ level\\ is\\ called\\ the\\ discriminatory\\ zone\\.\\ \\ the\\ discriminatory\\ zone\\ for\\ transabdominal\\ ultrasound\\ evaluation\\ is\\ higher\\,\\ at\\ 6500\\ iu\\/l\\.\\ \\ \\ a\\ negative\\ ultrasound\\ examination\\ at\\ hcg\\ levels\\ below\\ the\\ discriminatory\\ zone\\ is\\ consistent\\ with\\ an\\ early\\ viable\\ intrauterine\\ pregnancy\\ or\\ an\\ ectopic\\ pregnancy\\ or\\ nonviable\\ intrauterine\\ pregnancy\\.\\ \\ because\\ this\\ patient\\‚\\Ä\\ôs\\ clinical\\ examination\\ was\\ fairly\\ benign\\ and\\ the\\ quantitative\\ hcg\\ was\\ below\\ the\\ discriminatory\\ zone\\,\\ the\\ clinician\\ elected\\ to\\ delay\\ surgical\\ or\\ medical\\ treatment\\ for\\ ectopic\\ pregnancy\\ at\\ this\\ initial\\ evaluation\\.\\ \\ the\\ patient\\ returned\\ for\\ follow\\-up\\ examination\\ in\\ 48\\ hours\\ with\\ an\\ unchanged\\ clinical\\ picture\\ and\\ a\\ quantitative\\ hcg\\ level\\ of\\ 1217\\ iu\\/l\\.\\ \\ because\\ the\\ hcg\\ level\\ was\\ not\\ rising\\ at\\ the\\ predicted\\ rate\\ for\\ a\\ normal\\ iup\\,\\ laproscopic\\ surgical\\ intervention\\ was\\ performed\\ at\\ that\\ time\\.\\ \\ subsequent\\ follow\\-up\\ examinations\\ were\\ performed\\ until\\ the\\ quantitative\\ hcg\\ levels\\ returned\\ to\\ zero\\.\\ \\ ectopic\\ pregnancy\\ was\\ confirmed\\ by\\ histopathologic\\ evaluation\\.\ \(0\)\
\-\ a\\ complex\\ adnexal\\ mass\\ in\\ the\\ presence\\ of\\ a\\ quantitative\\ hcg\\ level\\ above\\ the\\ discriminatory\\ zone\\ and\\ empty\\ uterus\\ is\\ highly\\ suggestive\\ of\\ an\\ extrauterine\\ gestation\\ and\\ is\\ the\\ most\\ common\\ sonographic\\ abnormality\\,\\ these\\ findings\\ should\\ be\\ considered\\ to\\ represent\\ ectopic\\ pregnancy\\ until\\ proven\\ otherwise\\.\\ \\ nonspecific\\ findings\\ that\\ should\\ heighten\\ a\\ clinician\\'s\\ suspicion\\ of\\ ectopic\\ pregnancy\\ include\\ the\\ visualization\\ of\\ a\\ fluid\\ filled\\ adnexal\\ mass\\ surrounded\\ by\\ an\\ echogenic\\ ring\\ \\(bagel\\ sign\\)\\ and\\ free\\ fluid\\ in\\ the\\ peritoneal\\ cavity\\/cul\\-de\\-sac\\.\\ \\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ condous\\,\\ g\\,\\ kirk\\,\\ e\\,\\ lu\\,\\ c\\,\\ et\\ al\\.\\ \\ diagnostic\\ accuracy\\ of\\ varying\\ discriminatroy\\ zones\\ for\\ the\\ prediction\\ of\\ ectopic\\ pregnancy\\ in\\ women\\ with\\ a\\ pregnancy\\ of\\ unknown\\ location\\.ultrasound\\ obstet\\ gynecol\\.\\ 2005\\;\\ 26\\:770\\.\\ \ \(0\)\
\-\ daya\\,\\ s\\.\\ human\\ chorionic\\ gonadotropin\\ increase\\ in\\ normal\\ early\\ pregnancy\\.\\ am\\ j\\ obstet\\ gynecol\\ 1987\\;\\ 156\\:286\\.\ \(0\)\
\-\ gabrielli\\,\\ s\\,\\ romero\\,\\ r\\,\\ pilu\\,\\ g\\,\\ et\\ al\\.\\ accuracy\\ of\\ transvaginal\\ ultrasound\\ and\\ serum\\ hcg\\ in\\ the\\ diagnosis\\ of\\ ectopic\\ pregnancy\\.\\ ultrasound\\ obstet\\ gynecol\\ 1992\\;\\ 2\\:110\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pregnancy\\:\\ 0\\.09914450916694016\ \(0\)\
\-\ ectopic\\:\\ 0\\.07985195529944264\ \(0\)\
\-\ hcg\\:\\ 0\\.07208673521340371\ \(0\)\
\-\ discriminatory\\:\\ 0\\.06608334650649549\ \(0\)\
\-\ quantitative\\:\\ 0\\.061615526407197016\ \(0\)\
\-\ iu\\/l\\:\\ 0\\.0432148756313787\ \(0\)\
\-\ obstet\\:\\ 0\\.03470872324721914\ \(0\)\
\-\ gynecol\\:\\ 0\\.03470872324721914\ \(0\)\
\-\ zone\\:\\ 0\\.03402438009707978\ \(0\)\
\-\ adnexal\\:\\ 0\\.028312886727102835\ \(0\)\
\-\ transvaginal\\:\\ 0\\.027469872066855864\ \(0\)\
\-\ iup\\:\\ 0\\.027469872066855864\ \(0\)\
\-\ nonviable\\:\\ 0\\.024354936262088615\ \(0\)\
\-\ intrauterine\\:\\ 0\\.024352268556091492\ \(0\)\
\-\ ultrasound\\:\\ 0\\.022804700914599428\ \(0\)\
\-\ fallopian\\:\\ 0\\.022629664722855637\ \(0\)\
\-\ zero\\:\\ 0\\.02019813158106945\ \(0\)\
\-\ returned\\:\\ 0\\.01966806821953305\ \(0\)\
\-\ early\\:\\ 0\\.018741583026341456\ \(0\)\
\-\ level\\:\\ 0\\.018462436489107437\ \(0\)\
\-\ accuracy\\:\\ 0\\.017164845489080007\ \(0\)\
\-\ until\\:\\ 0\\.016879715401527128\ \(0\)\
\-\ clinician\\:\\ 0\\.016441720880933416\ \(0\)\
\-\ pelvic\\:\\ 0\\.01577474089909427\ \(0\)\
\-\ g\\:\\ 0\\.015155377236200706\ \(0\)\
\-\ rate\\:\\ 0\\.014980756328976804\ \(0\)\
\-\ evaluation\\:\\ 0\\.01488598978007081\ \(0\)\
\-\ s\\:\\ 0\\.014697257374000522\ \(0\)\
\-\ fluid\\:\\ 0\\.014564552351447395\ \(0\)\
\-\ h\\:\\ 0\\.013487347257661732\ \(0\)\
\-\ because\\:\\ 0\\.013446109369952238\ \(0\)\
\-\ \\,\\:\\ 0\\.013393451517347053\ \(0\)\
\-\ 909\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ 27y\\/o\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ queeziness\\.\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ usual\\.\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ fertilized\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ 1500\\-2000\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ 6500\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ 1217\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ bagel\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ cavity\\/cul\\-de\\-sac\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ condous\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ kirk\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ discriminatroy\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ location\\.ultrasound\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ 26\\:770\\.\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ daya\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ 156\\:286\\.\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ gabrielli\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ pilu\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ 2\\:110\\:\\ 0\\.013216669301299097\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.01250391450423572\ \(0\)\
\-\ an\\:\\ 0\\.012401280434772278\ \(0\)\
\-\ should\\:\\ 0\\.012252812032483358\ \(0\)\
\-\ lighter\\:\\ 0\\.012177468131044308\ \(0\)\
\-\ ovum\\:\\ 0\\.012177468131044308\ \(0\)\
\-\ 95\\-97\\:\\ 0\\.012177468131044308\ \(0\)\
\-\ menstral\\:\\ 0\\.012177468131044308\ \(0\)\
\-\ vitro\\:\\ 0\\.012177468131044308\ \(0\)\
\-\ heighten\\:\\ 0\\.012177468131044308\ \(0\)\
\-\ lu\\:\\ 0\\.012177468131044308\ \(0\)\
\-\ romero\\:\\ 0\\.012177468131044308\ \(0\)\
\-\ uterus\\:\\ 0\\.012078041023041837\ \(0\)\
\-\ period\\:\\ 0\\.01197972071472702\ \(0\)\
\-\ examination\\:\\ 0\\.011947929694788148\ \(0\)\
\-\ incidence\\:\\ 0\\.011747162290901308\ \(0\)\
\-\ above\\-described\\:\\ 0\\.011569574415739713\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.011487376640084508\ \(0\)\
\-\ fertilization\\:\\ 0\\.011138266960789516\ \(0\)\
\-\ bleeding\\:\\ 0\\.01112315727156197\ \(0\)\
\-\ below\\:\\ 0\\.01112315727156197\ \(0\)\
\-\ al\\:\\ 0\\.010862253592432647\ \(0\)\
\-\ g0p0\\:\\ 0\\.010803718907844675\ \(0\)\
\-\ 1970\\:\\ 0\\.010803718907844675\ \(0\)\
\-\ extrauterine\\:\\ 0\\.010803718907844675\ \(0\)\
\-\ prediction\\:\\ 0\\.010803718907844675\ \(0\)\
\-\ tube\\:\\ 0\\.010796349824160457\ \(0\)\
\-\ levels\\:\\ 0\\.010576465946842467\ \(0\)\
\-\ free\\:\\ 0\\.010546330007251758\ \(0\)\
\-\ predicted\\:\\ 0\\.010530373245484921\ \(0\)\
\-\ gonadotropin\\:\\ 0\\.010530373245484921\ \(0\)\
\-\ et\\:\\ 0\\.010486951814459616\ \(0\)\
\-\ implantation\\:\\ 0\\.010299262780976289\ \(0\)\
\-\ iud\\:\\ 0\\.010299262780976289\ \(0\)\
\-\ laproscopic\\:\\ 0\\.010299262780976289\ \(0\)\
\-\ chorionic\\:\\ 0\\.010299262780976289\ \(0\)\
\-\ complex\\:\\ 0\\.01026054236166158\ \(0\)\
\-\ irregular\\:\\ 0\\.010219929992522877\ \(0\)\
\-\ hours\\:\\ 0\\.010075554148752013\ \(0\)\
\-\ cul\\-de\\-sac\\:\\ 0\\.009922479530180326\ \(0\)\
\-\ 1987\\:\\ 0\\.009922479530180326\ \(0\)\
\-\ prior\\:\\ 0\\.009868573188316477\ \(0\)\
\-\ abdominal\\/pelvic\\:\\ 0\\.009764517737589884\ \(0\)\
\-\ histopathologic\\:\\ 0\\.009764517737589884\ \(0\)\
\-\ evaluations\\:\\ 0\\.009621623914794793\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.009569717894390284\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.009516076021074616\ \(0\)\
\-\ increased\\:\\ 0\\.009402480277959471\ \(0\)\
\-\ above\\:\\ 0\\.00939112040967861\ \(0\)\
\-\ endometrium\\:\\ 0\\.009371168015749566\ \(0\)\
\-\ awareness\\:\\ 0\\.009371168015749566\ \(0\)\
\-\ rising\\:\\ 0\\.009371168015749566\ \(0\)\
\-\ risk\\:\\ 0\\.009280979452351084\ \(0\)\
\-\ grayscale\\:\\ 0\\.009260061610721498\ \(0\)\
\-\ transabdominal\\:\\ 0\\.009260061610721498\ \(0\)\
\-\ human\\:\\ 0\\.009260061610721498\ \(0\)\
\-\ elected\\:\\ 0\\.009156624022285289\ \(0\)\
\-\ \\;\\:\\ 0\\.009109840427822759\ \(0\)\
\-\ viable\\:\\ 0\\.008968973133298773\ \(0\)\
\-\ a\\:\\ 0\\.008919036022907076\ \(0\)\
\-\ mass\\:\\ 0\\.008909003050581444\ \(0\)\
\-\ 1992\\:\\ 0\\.008883278359925537\ \(0\)\
\-\ zones\\:\\ 0\\.008725316567335092\ \(0\)\
\-\ at\\:\\ 0\\.00867888420413518\ \(0\)\
\-\ triad\\:\\ 0\\.008652167895416904\ \(0\)\
\-\ presumably\\:\\ 0\\.008582422744540004\ \(0\)\
\-\ menstrual\\:\\ 0\\.00845197090497534\ \(0\)\
\-\ lining\\:\\ 0\\.00845197090497534\ \(0\)\
\-\ empty\\:\\ 0\\.008331966845494776\ \(0\)\
\-\ rise\\:\\ 0\\.008275384644620944\ \(0\)\
\-\ groups\\:\\ 0\\.008220860440466708\ \(0\)\
\-\ periodic\\:\\ 0\\.008168249766086991\ \(0\)\
\-\ missed\\:\\ 0\\.008117422852030497\ \(0\)\
\-\ surgical\\:\\ 0\\.008078958486888096\ \(0\)\
\-\ unchanged\\:\\ 0\\.00806826269787309\ \(0\)\
\-\ non\\-distended\\:\\ 0\\.008020663450025145\ \(0\)\
\-\ examinations\\:\\ 0\\.007886312387521865\ \(0\)\
\-\ clinical\\:\\ 0\\.007883987406494765\ \(0\)\
\-\ tubes\\:\\ 0\\.007802999267349735\ \(0\)\
\-\ tenderness\\:\\ 0\\.007792840548370714\ \(0\)\
\-\ e\\:\\ 0\\.007612966725162113\ \(0\)\
\-\ caliber\\:\\ 0\\.007543221574285212\ \(0\)\
\-\ fairly\\:\\ 0\\.007509529136725905\ \(0\)\
\-\ picture\\:\\ 0\\.007509529136725905\ \(0\)\
\-\ varying\\:\\ 0\\.007509529136725905\ \(0\)\
\-\ s\\.\\:\\ 0\\.007509529136725905\ \(0\)\
\-\ or\\:\\ 0\\.007507666783835888\ \(0\)\
\-\ detection\\:\\ 0\\.007444334066351484\ \(0\)\
\-\ was\\:\\ 0\\.0074083772279886564\ \(0\)\
\-\ surrounded\\:\\ 0\\.0073218782477393884\ \(0\)\
\-\ proven\\:\\ 0\\.007292765675239985\ \(0\)\
\-\ endometrial\\:\\ 0\\.00726420766179067\ \(0\)\
\-\ this\\:\\ 0\\.007204926636537729\ \(0\)\
\-\ include\\:\\ 0\\.007187866530825447\ \(0\)\
\-\ secondary\\:\\ 0\\.007163508145453696\ \(0\)\
\-\ performed\\:\\ 0\\.007144162912225843\ \(0\)\
\-\ females\\:\\ 0\\.007129048595832203\ \(0\)\
\-\ consists\\:\\ 0\\.0070290615276183\ \(0\)\
\-\ gestation\\:\\ 0\\.00700507300985752\ \(0\)\
\-\ mortality\\:\\ 0\\.0069814622797703535\ \(0\)\
\-\ if\\:\\ 0\\.006952753924379716\ \(0\)\
\-\ ovary\\:\\ 0\\.006912782315705446\ \(0\)\
\-\ 2005\\:\\ 0\\.006912782315705446\ \(0\)\
\-\ gestational\\:\\ 0\\.006825844897938805\ \(0\)\
\-\ non\\-tender\\:\\ 0\\.006784196376039141\ \(0\)\
\-\ visualization\\:\\ 0\\.006763798097094945\ \(0\)\
\-\ called\\:\\ 0\\.00672381571766142\ \(0\)\
\-\ peritoneal\\:\\ 0\\.006665772970763833\ \(0\)\
\-\ suspicion\\:\\ 0\\.006646914226825512\ \(0\)\
\-\ nonspecific\\:\\ 0\\.006591720863822938\ \(0\)\
\-\ am\\:\\ 0\\.006591720863822938\ \(0\)\
\-\ abdominal\\:\\ 0\\.006404555436648022\ \(0\)\
\-\ by\\:\\ 0\\.006399719204999436\ \(0\)\
\-\ echogenic\\:\\ 0\\.00637356856446576\ \(0\)\
\-\ delay\\:\\ 0\\.006358032152118614\ \(0\)\
\-\ earlier\\:\\ 0\\.006327434143676025\ \(0\)\
\-\ in\\:\\ 0\\.00631779955232766\ \(0\)\
\-\ higher\\:\\ 0\\.006282677077484597\ \(0\)\
\-\ 48\\:\\ 0\\.006268050128541023\ \(0\)\
\-\ color\\:\\ 0\\.006253564504985196\ \(0\)\
\-\ place\\:\\ 0\\.006225006491535879\ \(0\)\
\-\ women\\:\\ 0\\.006225006491535879\ \(0\)\
\-\ the\\:\\ 0\\.006218108757284519\ \(0\)\
\-\ sac\\:\\ 0\\.006210928919796989\ \(0\)\
\-\ sonographic\\:\\ 0\\.006210928919796989\ \(0\)\
\-\ serum\\:\\ 0\\.006183164230490787\ \(0\)\
\-\ highly\\:\\ 0\\.0061694723510855795\ \(0\)\
\-\ c\\:\\ 0\\.006089847425577412\ \(0\)\
\-\ 80\\:\\ 0\\.00602657852829049\ \(0\)\
\-\ normal\\:\\ 0\\.006025243423983962\ \(0\)\
\-\ \\%\\:\\ 0\\.0059769746127316566\ \(0\)\
\-\ developmental\\:\\ 0\\.005954019996263728\ \(0\)\
\-\ filled\\:\\ 0\\.005954019996263728\ \(0\)\
\-\ ring\\:\\ 0\\.005954019996263728\ \(0\)\
\-\ most\\:\\ 0\\.005915547651358549\ \(0\)\
\-\ is\\:\\ 0\\.0059011026217287545\ \(0\)\
\-\ defects\\:\\ 0\\.005884811537848192\ \(0\)\
\-\ having\\:\\ 0\\.005884811537848192\ \(0\)\
\-\ r\\:\\ 0\\.005818657407549934\ \(0\)\
\-\ present\\:\\ 0\\.005787132695447318\ \(0\)\
\-\ j\\:\\ 0\\.005786643727684014\ \(0\)\
\-\ factors\\:\\ 0\\.005755299372632569\ \(0\)\
\-\ intervention\\:\\ 0\\.005704472458576075\ \(0\)\
\-\ represent\\:\\ 0\\.005626571800509042\ \(0\)\
\-\ 60\\:\\ 0\\.005589088588806768\ \(0\)\
\-\ count\\:\\ 0\\.0055706926478895046\ \(0\)\
\-\ last\\:\\ 0\\.0054733619940674424\ \(0\)\
\-\ suggestive\\:\\ 0\\.0054733619940674424\ \(0\)\
\-\ for\\:\\ 0\\.005465578325657534\ \(0\)\
\-\ but\\:\\ 0\\.005464777514343441\ \(0\)\
\-\ findings\\:\\ 0\\.0054537839154121725\ \(0\)\
\-\ defined\\:\\ 0\\.0053981749120802286\ \(0\)\
\-\ outside\\:\\ 0\\.00537392774679447\ \(0\)\
\-\ increase\\:\\ 0\\.00537392774679447\ \(0\)\
\-\ amount\\:\\ 0\\.005350066494461787\ \(0\)\
\-\ references\\:\\ 0\\.005326579063060889\ \(0\)\
\-\ stable\\:\\ 0\\.005280680058833592\ \(0\)\
\-\ tender\\:\\ 0\\.00520001633170769\ \(0\)\
\-\ treatment\\:\\ 0\\.005186257749927697\ \(0\)\
\-\ visualized\\:\\ 0\\.005185805321281088\ \(0\)\
\-\ considered\\:\\ 0\\.005171727749542198\ \(0\)\
\-\ diagnostic\\:\\ 0\\.005076720832102035\ \(0\)\
\-\ moderate\\:\\ 0\\.0050377770743760064\ \(0\)\
\-\ unknown\\:\\ 0\\.0049998193412661264\ \(0\)\
\-\ subsequent\\:\\ 0\\.0049873773580356995\ \(0\)\
\-\ 24\\:\\ 0\\.004981194873502173\ \(0\)\
\-\ classic\\:\\ 0\\.004908927854284965\ \(0\)\
\-\ within\\:\\ 0\\.004887950250033228\ \(0\)\
\-\ commonly\\:\\ 0\\.004834379975195864\ \(0\)\
\-\ confirmed\\:\\ 0\\.00481769055935052\ \(0\)\
\-\ throughout\\:\\ 0\\.004795723127885947\ \(0\)\
\-\ ago\\:\\ 0\\.004768708876757494\ \(0\)\
\-\ abnormality\\:\\ 0\\.004726473678906375\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.004710937266559229\ \(0\)\
\-\ wbc\\:\\ 0\\.00467027713729507\ \(0\)\
\-\ pelvis\\:\\ 0\\.004655309455159863\ \(0\)\
\-\ presence\\:\\ 0\\.004650353251060163\ \(0\)\
\-\ otherwise\\:\\ 0\\.004601672014132451\ \(0\)\
\-\ effect\\:\\ 0\\.004536069344931401\ \(0\)\
\-\ signs\\:\\ 0\\.004508809496230966\ \(0\)\
\-\ \\&\\:\\ 0\\.004499831922251022\ \(0\)\
\-\ to\\:\\ 0\\.004481974151575568\ \(0\)\
\-\ inflammatory\\:\\ 0\\.004442752540018026\ \(0\)\
\-\ sign\\:\\ 0\\.004438450527382415\ \(0\)\
\-\ that\\:\\ 0\\.004425729321015962\ \(0\)\
\-\ benign\\:\\ 0\\.004421364868115744\ \(0\)\
\-\ 3\\.\\:\\ 0\\.004383619508456863\ \(0\)\
\-\ of\\:\\ 0\\.004366709175336898\ \(0\)\
\-\ cases\\:\\ 0\\.004268082254844276\ \(0\)\
\-\ white\\:\\ 0\\.004249031803166443\ \(0\)\
\-\ initial\\:\\ 0\\.00424525058962415\ \(0\)\
\-\ flow\\:\\ 0\\.004233963833371089\ \(0\)\
\-\ 2\\.\\:\\ 0\\.004074129148126324\ \(0\)\
\-\ adjacent\\:\\ 0\\.004050729001700551\ \(0\)\
\-\ 1\\.\\:\\ 0\\.004001782858017392\ \(0\)\
\-\ be\\:\\ 0\\.003951294522770402\ \(0\)\
\-\ medical\\:\\ 0\\.003941993703247383\ \(0\)\
\-\ patient\\:\\ 0\\.003852737320463514\ \(0\)\
\-\ only\\:\\ 0\\.0038521913920313874\ \(0\)\
\-\ negative\\:\\ 0\\.003826267108508057\ \(0\)\
\-\ decreased\\:\\ 0\\.003809229989092293\ \(0\)\
\-\ infection\\:\\ 0\\.0037241627797193508\ \(0\)\
\-\ abnormal\\:\\ 0\\.0036538114547449946\ \(0\)\
\-\ weeks\\:\\ 0\\.003636098586058693\ \(0\)\
\-\ following\\:\\ 0\\.003636098586058693\ \(0\)\
\-\ time\\:\\ 0\\.0036185925445866756\ \(0\)\
\-\ she\\:\\ 0\\.003596381021670423\ \(0\)\
\-\ and\\:\\ 0\\.003508421401077721\ \(0\)\
\-\ high\\:\\ 0\\.0035060660585859303\ \(0\)\
\-\ presented\\:\\ 0\\.003492290307379924\ \(0\)\
\-\ than\\:\\ 0\\.0033568948349599306\ \(0\)\
\-\ common\\:\\ 0\\.0033527244557067424\ \(0\)\
\-\ these\\:\\ 0\\.0033340999879427884\ \(0\)\
\-\ anterior\\:\\ 0\\.0032995394659111506\ \(0\)\
\-\ symptoms\\:\\ 0\\.0031928897704619776\ \(0\)\
\-\ none\\:\\ 0\\.003177990265229395\ \(0\)\
\-\ consistent\\:\\ 0\\.00314137671488936\ \(0\)\
\-\ pain\\:\\ 0\\.003129259872655876\ \(0\)\
\-\ surgery\\:\\ 0\\.0031109431249779235\ \(0\)\
\-\ associated\\:\\ 0\\.003023182251735685\ \(0\)\
\-\ without\\:\\ 0\\.003016511493790345\ \(0\)\
\-\ small\\:\\ 0\\.0029513872329552\ \(0\)\
\-\ diagnosis\\:\\ 0\\.002941858067137061\ \(0\)\
\-\ were\\:\\ 0\\.002908975017526119\ \(0\)\
\-\ can\\:\\ 0\\.0029058805884093998\ \(0\)\
\-\ \\'s\\:\\ 0\\.002824657598751192\ \(0\)\
\-\ exam\\:\\ 0\\.002814443688080267\ \(0\)\
\-\ demonstrates\\:\\ 0\\.002798532536211673\ \(0\)\
\-\ have\\:\\ 0\\.0027742699825563594\ \(0\)\
\-\ had\\:\\ 0\\.002764392532594765\ \(0\)\
\-\ 2\\:\\ 0\\.002758777356087775\ \(0\)\
\-\ female\\:\\ 0\\.002633823495424038\ \(0\)\
\-\ no\\:\\ 0\\.002580042430895958\ \(0\)\
\-\ seen\\:\\ 0\\.0025316755848091305\ \(0\)\
\-\ on\\:\\ 0\\.0021705877432246718\ \(0\)\
\-\ \\(\\:\\ 0\\.00216600217764276\ \(0\)\
\-\ \\)\\:\\ 0\\.0021395433046875714\ \(0\)\
\-\ disease\\:\\ 0\\.002094059282182465\ \(0\)\
\-\ there\\:\\ 0\\.0019066200246851404\ \(0\)\
\-\ from\\:\\ 0\\.0018987042176225072\ \(0\)\
\-\ \\.\\:\\ 0\\.001862794247986686\ \(0\)\
\-\ not\\:\\ 0\\.0018513023564346856\ \(0\)\
\-\ history\\:\\ 0\\.0017694370880166168\ \(0\)\
\-\ \\:\\:\\ 0\\.0016945649415152399\ \(0\)\
\-\ with\\:\\ 0\\.0014033484388592471\ \(0\)\
\-\ right\\:\\ 0\\.0013517716778267115\ \(0\)\
